Stephen B Soumerai

Dados Biográficos

ID1739202
NOMEStephen B Soumerai
PRENOMESStephen B
SOBRENOMESoumerai
ASSINATURASOUMERAI S B
AFILIAÇÕESHarvard University
ORCID0000-0001-6811-2496
VERIFICADOSim
TOTAL DE OBRAS39
TOTAL DE CITAÇÕES56
TOTAL COMO AUTOR39
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO1986
ANO MAIS RECENTE DE PUBLICAÇÃO2021
ÍNDICE H4

  • Affordability of Medical Care Among Medicare Enrollees

    Open AccessJ M Madden, Susmitha Bayapureddy et al.ARTICLEJAMA Health Forum2021

    The findings of this study suggest that unaffordability of medical care is common among Medicare enrollees, especially those with lower incomes, or worse health, or who qualify for Medicare based on disability. Policy reforms, such as caps on patient spending, are needed to reduce Medical cost burdens on the most vulnerable enrollees

  • Cost-related Medication Nonadherence and Its Risk Factors Among Medicare Beneficiaries

    Farrah Nekui, Alison A Galbraith et al.ARTICLEMedical Care2021Referências: 21

    BACKGROUND: Unaffordability of medications is a barrier to effective treatment. Cost-related nonadherence (CRN) is a crucial, widely used measure of medications access. OBJECTIVES: Our study examines the current national prevalence of and risk factors for CRN (eg, not filling, skipping or reducing doses) and companion measures in the US Medicare population. RESEARCH DESIGN: Survey-weighted analyses included logistic regression and trends 2006-201…

  • Reduced Cost-sharing for Preventive Drugs Preferentially Benefits Low-income Patients With Diabetes in High Deductible Health Plans With Health Savings Accounts

    Dennis Ross-Degnan, Jamie Wallace et al.ARTICLEMedical Care2020Referências: 29

    BACKGROUND: High deductible health plans linked to Health Savings Accounts (HSA-HDHPs) must include all care under the deductible except for select preventive services. Some employers and insurers have adopted Preventive Drug Lists (PDLs) that exempt specific classes of medications from deductibles. OBJECTIVE: The objective of this study was to examine the association between shifts to PDL coverage and medication utilization among patients with d…

  • Counter-Point

    Christine Y Lu, Gregory Simon et al.ARTICLEMedical Care2018Referências: 6

    Sequential analysis can be used as an early warning system about potential unintended consequences of health policy decisions, generating follow-up investigations, but it should not be used as causal evidence

  • Counter-Point

    Christine Y Lu, Gregory Simon et al.ARTICLEMedical Care2018Referências: 32

    Despite the good intentions of the Food and Drug Administration (FDA), many drug warnings are ineffective or have unintended consequences, particularly if the media exaggerates the messages and scares the public. The controversial 2003 to 2004 FDA warnings on youth suicidality associated with antidepressant use are a case in point. In a 10-year interrupted time series (ITS) analysis in 11 health plans, we found that the warnings and hyped media c…

  • Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis

    Christine Y Lu, Robert B Penfold et al.ARTICLEMedical Care2018Referências: 44

    BACKGROUND: New health policies may have intended and unintended consequences. Active surveillance of population-level data may provide initial signals of policy effects for further rigorous evaluation soon after policy implementation. OBJECTIVE: This study evaluated the utility of sequential analysis for prospectively assessing signals of health policy impacts. As a policy example, we studied the consequences of the widely publicized Food and Dr…

  • The Effects of the Transition From Medicaid to Medicare on Health Care Use for Adults With Mental Illness

    Margaret E Burns, Marguerite E Burns et al.ARTICLEMedical Care2016Referências: 27

    BACKGROUND: The transition from Medicaid-only to dual Medicare/Medicaid coverage has the potential to reduce financial barriers to health care for patients with serious mental illness through increased coverage or expanded access to clinicians as their reimbursement increases. AIMS: To estimate the effect of dual coverage after Medicaid enrollment during the required waiting period among adults with serious mental illness on health care use, over…

  • Colorectal Cancer Screening in a Nationwide High-deductible Health Plan Before and After the Affordable Care Act

    J Frank Wharam, Fang Zhang et al.ARTICLEMedical Care2016Referências: 22

    BACKGROUND: Little is known about the effect of the Affordable Care Act's (ACA) elimination of out-of-pocket costs for preventive services. This policy likely reduced out-of-pocket colonoscopy costs most for high-deductible health plan (HDHP) members. OBJECTIVES: Determine the ACA's impact on colorectal cancer screening among HDHP members. RESEARCH DESIGN: Pre-post with comparison group, constructed before and after the ACA. SUBJECTS: We studied …

  • Impact of a High-deductible Health Plan on Outpatient Visits and Associated Diagnostic Tests

    Sheila R Reddy, Dennis Ross-Degnan et al.ARTICLEMedical Care2014Referências: 3

    BACKGROUND: By shifting a greater share of out-of-pocket medical costs to consumers, high-deductible health plans (HDHP) might discourage use of essential outpatient services. OBJECTIVE: The objective of the study was to examine the impact of an HDHP on outpatient visits and associated laboratory and radiology tests. RESEARCH DESIGN/SUBJECTS: We used a pre-post with comparison group study design to examine the differential change in outpatient se…

  • Persistent Medication Affordability Problems Among Disabled Medicare Beneficiaries After Part D, 2006–2011

    Huseyin Naci, Stephen B Soumerai et al.ARTICLEMedical Care2014Referências: 28

    BACKGROUND: Disabled Americans who qualify for Medicare coverage typically have multiple chronic conditions, are highly dependent on effective drug therapy, and have limited financial resources, putting them at risk for cost-related medication nonadherence (CRN). Since 2006, the Part D benefit has helped Medicare beneficiaries afford medications. OBJECTIVE: To investigate recent national trends in medication affordability among this vulnerable po…

  • Changes in Use of Lipid-lowering Medications Among Black and White Dual Enrollees With Diabetes Transitioning From Medicaid to Medicare Part D Drug Coverage

    Alyce S Adams, J M Madden et al.ARTICLEMedical Care2014Referências: 3

    BACKGROUND: The use of lipid-lowering agents is suboptimal among dual enrollees, particularly blacks. OBJECTIVES: To determine whether the removal of restrictive drug caps under Medicare Part D reduced racial differences among dual enrollees with diabetes. RESEARCH DESIGN: An interrupted time series with comparison series design (ITS) cohort study. SUBJECTS: A total of 8895 black and white diabetes patients aged 18 years and older drawn from a na…

  • Health care payments in the asia pacific

    Open AccessSheila R Reddy, Dennis Ross-Degnan et al.ARTICLEInternational Journal for Equity…2013

    Studies that examine economic burden attributable to health care payments should include measures of impoverishment and indebtedness

  • Two-year Trends in Colorectal Cancer Screening After Switch to a High-deductible Health Plan

    J Frank Wharam, Amy Johnson Graves et al.ARTICLEMedical Care2011

    BACKGROUND: Recent health reform laws might accelerate high-deductible health plan (HDHP) growth. The impact of HDHPs on long-term colorectal cancer screening rates and low socioeconomic status (SES) members is unknown. METHODS: We studied colorectal cancer screening rates among 1306 Health Maintenance Organization (HMO) members for 1 year before and 2 years after an employer-mandated switch to HDHPs, compared with 1306 propensity score-matched c…

  • Medicare Part D and Changes in Prescription Drug Use and Cost Burden

    Becky A Briesacher, Yanfang Zhao et al.ARTICLEMedical Care2011

    CONTEXT: The full effect of Medicare Part D, after the initial policy transition period and across the United States Medicare population, remains unclear. OBJECTIVE: To estimate nationally representative changes in prescription drug use and out-of-pocket drug costs 2 years after implementation of Part D. DESIGN, SETTING, AND PARTICIPANTS: We examined study outcomes over 8 years (2000 to 2007) and estimated changes after Part D, accounting for ear…

  • Out-of-Pocket Burden of Health Care Spending and the Adequacy of the Medicare Part D Low-Income Subsidy

    Becky A Briesacher, Dennis Ross-Degnan et al.ARTICLEMedical Care2010Referências: 10

    BACKGROUND: Evaluating the adequacy of Medicare prescription drug program (Part D) and its low-income subsidy (LIS) requires a comprehensive understanding of drug spending in relation to household resources. OBJECTIVE: : To estimate out-of-pocket health care costs in the year before Part D, in context of total household spending, health status, and LIS eligibility. RESEARCH DESIGN: Nationally representative cross-sectional study. SUBJECTS: Two th…

  • Unintended Impacts of a Medicaid Prior Authorization Policy on Access to Medications for Bipolar Illness

    Christine Y Lu, Stephen B Soumerai et al.ARTICLEMedical Care2010Referências: 23

    OBJECTIVES: Prior authorization policies (PA) are widely used to control psychotropic medication costs by state Medicaid programs and Medicare Part D plans. The objective of this study was to examine the impact of a Maine Medicaid PA policy on initiation and switching of anticonvulsant and atypical antipsychotic treatments among patients with bipolar disorder. METHODS: We obtained Maine and New Hampshire (comparison state) Medicaid and Medicare c…

  • Medicaid Prior Authorization and Controlled-Release Oxycodone

    Nancy E Morden, Judy T Zerzan et al.ARTICLEMedical Care2008Referências: 19

    BACKGROUND: Since its introduction in 1996, controlled-release (CR) oxycodone use has increased steadily despite its high cost. To control use and expenditures, many Medicaid programs have implemented CR oxycodone prior authorization (PA) policies. Few studies evaluate Medicaid policies or compare lenient and strict policies in multiple states. OBJECTIVE: To estimate the impact of PA on CR oxycodone use by Medicaid beneficiaries. DESIGN: Secondar…

  • Reliability of New Measures of Cost-Related Medication Nonadherence

    Marsha Pierre-Jacques, Dana Gelb Safran et al.ARTICLEMedical Care2008Referências: 8

    BACKGROUND: Although several national studies have attempted to measure medication nonadherence due to cost in cross-sectional studies of the elderly and disabled, little information exists on the psychometric properties of these measures over time. OBJECTIVES: Examine the test-retest reliability of several recently published measures of cost-related medication nonadherence, among elderly community. METHODS: We developed a questionnaire and teste…

  • Academic Detailing to Improve Laboratory Testing Among Outpatient Medication Users

    Jennifer Elston Lafata, Margaret J Gunter et al.ARTICLEMedical Care2007Referências: 27

    PURPOSE: To determine whether group academic detailing with performance feedback increases recommended laboratory monitoring among outpatients dispensed medications. METHODS: Thirty-eight primary care practices in 3 states were randomized to group academic detailing with physician-level performance feedback (intervention) or a control group. Adjusted differences in creatinine and potassium testing between intervention and control group patients w…

  • Racial Differences in Impact of Coverage on Diabetes Self-Monitoring in a Health Maintenance Organization

    Connie A Mah, Connie Mah et al.ARTICLEMedical Care2006Referências: 18

    BACKGROUND: Insurance coverage of patient self-management devices like self-monitoring blood glucose (SMBG) equipment may help to reduce race-related barriers to effective care. OBJECTIVES: We examined whether providing free home glucose monitors had greater impacts on self-monitoring among black versus white patients with diabetes. RESEARCH DESIGN: Using electronic medical record data (1992-1996), we used longitudinal survival analysis to examin…

  • Trends and Geographic Variation of Opiate Medication Use in State Medicaid Fee-For-Service Programs, 1996 to 2002

    Judy T Zerzan, Judy Zerzan et al.ARTICLEMedical Care2006Referências: 27

    BACKGROUND: Although studies have documented hospital and surgical service geographic variability, prescription use geographic variability is largely unknown. Opiate pain medications are widely used, particularly because the promulgation of clinical guidelines promoting aggressive pain treatment. This study describes temporal and interstate variability in aggregate prescription opiate medication use within U.S. Medicaid programs. METHODS: A datas…

  • Differential Effect of Early or Late Implementation of Prior Authorization Policies on the Use of Cox II Inhibitors

    Elizabeth E Roughead, Fang Zhang et al.ARTICLEMedical Care2006Referências: 7

    BACKGROUND: State Medicaid programs introduce many types of prescribing restrictions to manage pharmaceutical use and expenditure. Little is known about the differential effect of implementing prior authorization (PA) policies at market entry versus waiting until several years later when prescribing behavior may already be established. OBJECTIVES: We sought to examine the impact on overall use of Cox II inhibitors of PA policies implemented at ma…

  • Systematic Review

    Open AccessNiteesh K Choudhry, Robert H Fletcher et al.ARTICLEAnnals of Internal Medicine2005

  • Antibiotic use following a Korean national policy to prohibit medication dispensing by physicians

    Open AccessSylvia Park, Stephen B Soumerai et al.ARTICLEHealth Policy and Planning2005Citada por: 5Referências: 22

    This study investigated whether a Korean national policy prohibiting doctors from dispensing drugs as of 2000 selectively reduced inappropriate antibiotic prescribing in viral illness compared with bacterial illness. We assessed the proportions of episodes prescribed an antibiotic and the number of different antibiotics prescribed for patients with viral and bacterial illness episodes before and after the policy. The nationally representative sam…

  • Effect of Increased Cost-Sharing on Oral Hypoglycemic Use in Five Managed Care Organizations

    Douglas W Roblin, Richard Platt et al.ARTICLEMedical Care2005Referências: 29

    BACKGROUND: For patients with a chronic disease, increased cost-sharing for medications may lead to unintended consequences, including reduced use of medications essential for control of their disease. OBJECTIVE: The objective of this study was to estimate the effects of small ($1-6 per 30-day supply), moderate ($7-10), and large (>$10) increases in medication cost-sharing on 12-month trends in oral hypoglycemic (OH) use among adults with type 2 …